Villa Sistemi boosts Del Global in Europe
Officials at x-ray manufacturer Del Global Technologies believe the company has added an important European dimension to its Valhalla, NY-based business by increasing its ownership in Villa Sistemi Medicali, an Italian radiographic/fluoroscopic firm.In
Officials at x-ray manufacturer Del Global Technologies believe the company has added an important European dimension to its Valhalla, NY-based business by increasing its ownership in Villa Sistemi Medicali, an Italian radiographic/fluoroscopic firm.
In January, Del Global obtained a 19% stake in Villa along with the nonrevocable option to increase its share to 80%.
In April, Del Global decided to exercise its option.
Villa Sistemi has annual sales of $20 million. Its line of radiographic/fluoroscopic systems and a line of portable imaging systems with power ratings up to 30 kW complements Del Globals existing line of products, said Leonard Trugman, Del Globals president.
Getting into the European imaging market has been one of Del Globals goals over the last five years, Trugman said. Before the Villa Sistemi acquisition, medical salessystems and subsystemsaccounted for 80% of Del Globals total sales (SCAN 2/2/00). The acquisition drives that to 90%.
Prior to 1990, Del Global manufactured mostly defense electronics.
The company shifted toward medical imaging in the early 1990s, primarily by acquiring companies that specialized in niche technologies Del Global lacked (SCAN 2/2/00).
Del Global purchased x-ray and mammography firm DynaRad in 1992, and in 1996 bought Gendex Medical from Dentsply International. In 1998, Del Global acquired Acoma Medical Imaging for $1.4 million. That year, the company posted the strongest fourth-quarter and fiscal-year results in its history. Year-end sales for 1998 were $62.3 million (SCAN 11/11/98).
Can MRI-Guided Transurethral Ultrasound Ablation Have an Impact for Localized Prostate Cancer?
December 11th 2023Follow-up MRI imaging one year after transurethral ultrasound ablation revealed approximately 50 percent decreases in prostate volume and median PSA density, according to recently presented research findings at the 2023 Society of Urologic Oncology (SUO) Annual Meeting.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.
